Find verified Tofisopam API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Tofisopam for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Tofisopam API.
Alternate Names: Emandaxin, Tofizopam, Grandaxin, Seriel
CAS No: 22345-47-7
PubChem CID: 5502
Mol Formula: C22H26N2O4
Mol Weight: 382.5 g/mol
IUPAC Name: 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine
API Description: Tofisopam (marketed under brand names Emandaxin and Grandaxin) is a 2,3-benzodiazepine drug which is a benzodiazepine derivative. In contrast to classical 1,4-benzodiazepines, the compound does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor and its psychopharmacological profile differs from such compounds. Although Tofisopam is not approved for sale in North America, it is approved for use in various countries worldwide, including parts of Europe. The D-enantiomer (dextofisopam) is currently in phase II trials in the U.S. for the treatment of irritable bowel syndrome.
